{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-22-017806","form_type":"8-K","ticker":"BVS","cik":"0001665988","company_name":"Bioventus Inc.","filed_at":"2022-06-22T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.711876+00:00","generated_at":"2026-06-25T00:01:19.267397+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Bioventus amends CartiHeal acquisition, defers $215M upfront, lowers sales milestone to $75M","bullets":["Deferred $215M of $315M upfront; paid in five tranches 2023–2027 with 8% annual interest.","Contingent ~$135M now triggered at $75M trailing sales (down from $100M).","Expected close by end of July 2022; upfront ~$100M (incl. $50M escrowed).","Bioventus to pay ~$8M of CartiHeal's transaction fees.","Additional milestones: First Paper $50M, Additional Publication $25M, etc., with interest."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-22-017806","json":"https://secwatch.observer/filing/0001628280-22-017806.json","markdown":"https://secwatch.observer/filing/0001628280-22-017806.md","text":"https://secwatch.observer/filing/0001628280-22-017806.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1665988/000162828022017806/0001628280-22-017806-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1665988/000162828022017806/bvs-20220617.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T00:01:19.267397+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}